Must Read Articles

Pills

Innovation in non-Hodgkin lymphoma drug discovery: What needs to be done?

Authors: Witkowska M, Smolewski P, Majchrzak A, Robak T Published in: Expert Opin Drug Discov. 2016 Aug 27.Abstract A new generation...

Second-Generation of Tunable pH-Sensitive Phosphoramidate-Based Linkers for Controlled Release

Authors: Choy CJ, Ley CR, Davis AL, Backer BS, Geruntho JJ, Clowers BH, Berkman CE. Published in: Bioconjug Chem. 2016...
Healthcare And Medicine. Doctor using a digital tablet

Antibody-drug Conjugates and Mechanisms of Resistance

An article published in the December 2016 issue of Molecular Cancer Therapeutics by Frank Loganzo, Matthew Sung and Hans-Peter...
Leukemia

Tumour cell surface antigen targeted therapies in B-cell lymphomas: Beyond rituximab.

Authors: Aku M, Chong G, Hawkes EA. Published in: Blood Rev. 2016 Aug 12. pii: S0268-960X(16)30051-0. doi: 10.1016/j.blre.2016.08.001.Abstract Recent proliferation of...
IgG1 monoclonal antibody (immunoglobulin)

Strategies of Targeting the Extracellular Domain of RON Tyrosine Kinase Receptor for Cancer Therapy...

Authors: Zarei O, Benvenuti S, Ustun-Alkan F, Hamzeh-Mivehroud M, Dastmalchi S. Title: Strategies of targeting the extracellular domain of RON...

Effects of Antibody, Drug and Linker on the Preclinical and Clinical Toxicities of Antibody-drug...

Authors: Donaghy H. Title: Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates Published in:...

Combination of Small Molecule Prodrug and Nanodrug Delivery: Amphiphilic Drug-drug Conjugate for Cancer Therapy.

Authors: Huang P, Wang D, Su Y, Huang W, Zhou Y, Cui D, Zhu X, Yan D.All drugs for...